New 'Off-the-Shelf' cell therapy takes on tough blood cancers
NCT ID NCT07131254
First seen Jan 05, 2026 · Last updated May 22, 2026 · Updated 19 times
Summary
This early-stage study tests a new treatment called GT719 for adults with certain blood cancers (B-cell lymphoma or leukemia) that have come back or not responded to standard therapy. The treatment uses specially engineered immune cells that are made from a healthy donor, so they can be given to many patients without needing a personalized match. The main goals are to check the treatment's safety and see how well it works in 34 participants.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOLOGICAL MALIGNANCY (LEUKEMIA- LYMPHOMA) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ganzhou City People's Hospital
RECRUITINGGanzhou, Jiangxi, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.